Appointment Adherence and Disparities in Outcomes Among Patients with Diabetes

  • Joel M. SchectmanEmail author
  • John B. Schorling
  • John D. Voss



Successful control of diabetes mellitus requires lifelong adherence to multiple self-management activities in close collaboration with health professionals. We examined the association of such control with appointment keeping behavior in a rural health system.


Among 4,253 predominantly lower socioeconomic status patients with diabetes, the association of metabolic control (most recent A1c <7% or >9% in two models of respectively ‘good’ and ‘poor’ control) with ‘missed appointment rate’ over a 3-year period was examined using multiple logistic regression.

Main Results

For each 10% increment in missed appointment rate, the odds of good control decreased 1.12× (p < 0.001) and the odds of poor control increased 1.24× (p < 0.001). The missed appointment rate was substantially higher among African-American patients (15.9% vs. 9.3% for white patients, p < 0.001). Controlling for the missed appointment rate and insurance status in multivariate analysis attenuated the racial association with good control, and the racial association with poor control was no longer significant. Older, white patients with health insurance tended to have significantly better metabolic control. There was no independent association of metabolic control with patient income, gender, or number of primary care visits.


Adherence to appointments, independent of visit frequency, was a strong predictor of diabetes metabolic control. We hypothesize that missed appointment behavior may serve as an indicator for other diabetes adherence behaviors and associated barriers that serve to undermine successful diabetes self-management.


appointment adherence a1c diabetes mellitus 



An abstract describing this study was presented at the Society of General Internal Medicine 31st Annual National Meeting in Pittsburgh (April, 2008). The study was conducted without external or additional internal funding.

Conflict of Interest

None disclosed.


  1. 1.
    Schectman JM, Nadkarni MM, Voss JD. Diabetes metabolic control and medication adherence in an indigent population. Diab Care. 2002;25:1015–1021.CrossRefGoogle Scholar
  2. 2.
    Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167:1853–60.PubMedCrossRefGoogle Scholar
  3. 3.
    Blonde L, Karter AJ. Current evidence regarding the value of self-monitored blood glucose testing. Am J Med. 2005;118(9a):20–26s.CrossRefGoogle Scholar
  4. 4.
    Karter AJ, Parker MM, Moffett HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diab Care. 2006;29:1757–63.CrossRefGoogle Scholar
  5. 5.
    Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111:1–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.PubMedCrossRefGoogle Scholar
  7. 7.
    Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.PubMedCrossRefGoogle Scholar
  8. 8.
    Karter AJ, Parker MM, Moffet HH, et al. Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care. 2004;42:110–15.PubMedCrossRefGoogle Scholar
  9. 9.
    Pincus T, Esther R, DeWalt DA, Callahan LF. Social conditions and self-management are more powerful determinants of health than access to care. Ann Intern Med. 1998;129:406–11.PubMedGoogle Scholar
  10. 10.
    Selby JV, Swain BE, Gerzoff RB, et al. Understanding the gap between good processes of diabetes care and poor intermediate outcomes. Translating research into action for diabetes. Med Care. 2007;45:1144–53.PubMedCrossRefGoogle Scholar
  11. 11.
    Shenolikar RA, Balkrishnan R, Camacho FT, et al. Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Nat Med Assoc. 2006;98(7):1071–7.Google Scholar
  12. 12.
    Hill-Briggs F, Gary TL, Bone LR, Hill MN, Levine DM, Brancati FL. Medication adherence and diabetes control in urban African Americans with type 2 diabetes. Health Psychol. 2005;24(4):349–57.PubMedCrossRefGoogle Scholar
  13. 13.
    Trinacty CM, Adams AS, Soumerai SB, et al. Racial differences in long-term self-monitoring practice among newly drug-treated diabetes patients in an HMO. J Gen Intern Med. 2007;22:1506–13.PubMedCrossRefGoogle Scholar
  14. 14.
    Harris MI, Cowie CC, Howie LJ. Self-monitoring of blood glucose by adults with diabetes in the United States population. Diab Care. 1993;16(8):1116–23.CrossRefGoogle Scholar
  15. 15.
    Griffin SJ. Lost to follow-up: the problem of defaulters from diabetes clinics. Diabet Med. 1998;15(supp 3):S14–24.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2008

Authors and Affiliations

  • Joel M. Schectman
    • 1
    Email author
  • John B. Schorling
    • 1
  • John D. Voss
    • 1
  1. 1.Department of MedicineUniversity of Virginia Health SystemCharlottesvilleUSA

Personalised recommendations